Trial intelligence / Profile preview

SPSIPB vs ISCB for Postoperative Analgesia After Arthroscopic Shoulder Surgery

NCT07278050Recruiting

Sponsor
Istanbul Medipol University
Start
Jan 2026
Primary completion
Sep 2026
Countries
1
01

Overview

Randomised, single-blind trial in shoulder pain and Shoulder disorder (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Opioid consumption (fentanyl) at 24 hours. Started Jan 2026; status: recruiting.

02

Conditions

shoulder painShoulder disorder

Beyond the preview

Go deeper on NCT07278050.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07278050.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call